138 related articles for article (PubMed ID: 19857167)
1. Fever, shock, and pancytopenia in a patient treated with alemtuzumab.
Bauer MP; van Burgel ND; Marijt WA; van Dissel JT; von dem Borne PA
Clin Infect Dis; 2009 Nov; 49(10):1540; 1616-7. PubMed ID: 19857167
[No Abstract] [Full Text] [Related]
2. Alemtuzumab treatment for hemophagocytic lymphohistiocytosis.
Machaczka M; Vaktnäs J; Chiang SC; Bryceson YT
Nat Rev Clin Oncol; 2010 Oct; 7(10):. PubMed ID: 21080519
[No Abstract] [Full Text] [Related]
3. Tuberculosis due to Mycobacterium bovis after alemtuzumab administration.
Abad S; Gyan E; Moachon L; Bouscary D; Sicard D; Dreyfus F; Blanche P
Clin Infect Dis; 2003 Jul; 37(2):e27-8. PubMed ID: 12856232
[TBL] [Abstract][Full Text] [Related]
4. [Alemtuzumab in early multiple sclerosis].
Killestein J; Polman CH
Ned Tijdschr Geneeskd; 2009 Jan; 153(1-2):46. PubMed ID: 19198214
[No Abstract] [Full Text] [Related]
5. Severe hemophagocytic syndrome developing after treatment initiation for disseminated Mycobacterium tuberculosis: case report and literature review.
Balkis MM; Bazzi L; Taher A; Salem Z; Uthman I; Kanj N; Boulos FI; Kanj SS
Scand J Infect Dis; 2009; 41(6-7):535-7. PubMed ID: 19449255
[TBL] [Abstract][Full Text] [Related]
6. Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.
Strout MP; Seropian S; Berliner N
Nat Rev Clin Oncol; 2010 Jul; 7(7):415-20. PubMed ID: 20404855
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium vivax malaria-associated hemophagocytic lymphohistiocytosis in a young man with pancytopenia and fever.
Bae E; Jang S; Park CJ; Chi HS
Ann Hematol; 2011 Apr; 90(4):491-2. PubMed ID: 20721557
[No Abstract] [Full Text] [Related]
8. Mycobacterium haemophilum infection after alemtuzumab treatment.
Kamboj M; Louie E; Kiehn T; Papanicolaou G; Glickman M; Sepkowitz K
Emerg Infect Dis; 2008 Nov; 14(11):1821-3. PubMed ID: 18976587
[No Abstract] [Full Text] [Related]
9. A 21-year-old man with Still's disease with fever, rash, and pancytopenia.
Mehta BM; Hashkes PJ; Avery R; Deal CL
Arthritis Care Res (Hoboken); 2010 Apr; 62(4):575-9. PubMed ID: 20391515
[No Abstract] [Full Text] [Related]
10. [Case of tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient under steroid therapy].
Hori M; Yoshida R; Aoyama I; Ichida S
Nihon Jinzo Gakkai Shi; 2009; 51(8):1091-5. PubMed ID: 19999590
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium avium complex infection after alemtuzumab therapy for chronic lymphocytic leukemia.
Saadeh CE; Srkalovic G
Pharmacotherapy; 2008 Feb; 28(2):281-4. PubMed ID: 18225973
[TBL] [Abstract][Full Text] [Related]
12. Alemtuzumab.
Williamson TS
Clin J Oncol Nurs; 2001; 5(6):287-8. PubMed ID: 11899633
[No Abstract] [Full Text] [Related]
13. Alemtuzumab: the future of chronic inflammatory demyelinating polyradiculoneuropathy treatment?
Brannagan TH; Patterson SK
Expert Rev Clin Immunol; 2010 May; 6(3):319-21. PubMed ID: 20441416
[No Abstract] [Full Text] [Related]
14. Life-threatening hemophagocytic syndrome related to mycobacterium tuberculosis.
Claessens YE; Pene F; Tulliez M; Cariou A; Chiche JD
Eur J Emerg Med; 2006 Jun; 13(3):172-4. PubMed ID: 16679883
[TBL] [Abstract][Full Text] [Related]
15. Taking the measure of alemtuzumab.
Gilleece MH
Leuk Res; 2004 Dec; 28(12):1253-4. PubMed ID: 15475064
[No Abstract] [Full Text] [Related]
16. Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation.
Karlsson C; Norin S; Kimby E; Sander B; Porwit Macdonald A; Nilsson B; Johansson E; Mellstedt H; Lundin J; Osterborg A
Leukemia; 2006 Dec; 20(12):2204-7. PubMed ID: 17051245
[No Abstract] [Full Text] [Related]
17. Fungal and mycobacterial infections after Campath (alemtuzumab) induction for renal transplantation.
Walsh R; Ortiz J; Foster P; Palma-Vargas J; Rosenblatt S; Wright F
Transpl Infect Dis; 2008 Jul; 10(4):236-9. PubMed ID: 18086280
[TBL] [Abstract][Full Text] [Related]
18. No cardiac toxicity associated with alemtuzumab therapy for mycosis fungoides/Sézary syndrome.
Lundin J; Kennedy B; Dearden C; Dyer MJ; Osterborg A
Blood; 2005 May; 105(10):4148-9. PubMed ID: 15867423
[No Abstract] [Full Text] [Related]
19. Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis.
Cooles FA; Jackson GH; Menon G; Isaacs JD
Rheumatology (Oxford); 2011 Apr; 50(4):810-2. PubMed ID: 21208978
[No Abstract] [Full Text] [Related]
20. Haemophagocytic lymphohistiocytosis: an uncommon clinical presentation of tuberculosis.
Shea YF; Chan JF; Kwok WC; Hwang YY; Chan TC; Ni MY; Li IW; Chiu PK; Luk JK; Chu LW
Hong Kong Med J; 2012 Dec; 18(6):517-25. PubMed ID: 23223654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
